(1) describe the energy intake and energy expenditure of mutant obese mice (ob/ob) in which the gene for neuropeptide Y (NPY) is disrupted. They conclude that deficiency of NPY in the ob/ob mouse reduces the elevated food intake and increases the low energy expenditure, partially ameliorating the obesity. Another report, by Mary Ann Pelleymounter et al. (2), describes energy intake and energy expenditure of ob/ob mice treated with OB protein or saline. They conclude that treatment with OB protein (leptin) reduces food intake and increases energy expenditure, ameliorating the obesity.
Response:
The comment by Himms-Hagen reveals the complexity of using basal oxygen consumption rates to compare the metabolic activity of animals that differ greatly in body size, body composition, and other characteristics. If oxygen consumption is calculated on a per-whole-animal basis, rather than on a per-weight basis, then there is no significant difference between NPY-deficient ob/ob mice (71.3 Ϯ 2.9 ml per hour per mouse) and control ob/ob mice (71.5 Ϯ 3.1 ml per hour per mouse); similarly, when calculated in this manner, leptin treatment does not raise the oxygen consumption rate of ob/ob mice (see the response by Pelleymounter et al.) . However, these results do not necessarily mean that the leaner phenotypes produced by NPY deficiency and leptin treatment are unrelated to changes in metabolic activity.
A problem in interpreting these data is that the measurements were obtained when significant differences in physical characteristics-such as body weight and body adiposity, which themselves affect oxygen consumption-existed between the groups of mice being compared. For example, the larger size of the control ob/ob mice necessitates that they devote greater metabolic activity to cardiac output, body support, and other physiological processes influenced by body size. The difficulty in comparing whole-animal oxygen consumption rates of animals varying profoundly in size and composition is exemplified by studies showing that adult ob/ob mice consume as much oxygen as or more than normal lean mice (1, 2) . On the basis of this information, one might mistakenly conclude that the obesity of ob/ob mice develops despite a seemingly normal or faster-than-normal metabolic rate, an assertion that directly conflicts with studies demonstrating that a metabolic component contributes to the onset of obesity in these mice (2) (3) (4) (5) . We therefore expressed oxygen consumption on a per-weight basis to more accurately reflect metabolic efficiency (6), a strategy used by other investigators (2, 7, 8) .
Regardless of one's interpretation of the oxygen consumption measurements, NPY deficiency and leptin treatment both resulted in increases in body temperature and physical activity of ob/ob mice (6,9), effects that would tend to promote increased energy expenditure and hence to reduce adiposity. Further studies are needed to define the complicated effects of leptin treatment and NPY deficiency on the metabolism of ob/ob mice. Examination of whole-animal oxygen consumption rates before drastic changes in body weight and composition occur as well as pair-feeding studies could provide essential information. ], that is, as a power function, not as a mass function. Power functions are used as a mass-independent method of expressing the average volume of oxygen (vO 2 ) consumed, reflecting surface area rather than mass (2) . One assumes, with power functions, that surface area should directly reflect metabolizable tissue. However, when there is as large a discrepancy in mass as there is between the ob/ob mouse and its lean littermate (even at 5 to 6 weeks of age), the power function is no longer independent of mass. When our data were analyzed in units of milliliters per mouse (as suggested by Himms-Hagen), there were no significant differences in vO 2 between ob/ob and lean mice, which is consistent with earlier data expressed in the same manner (3). Needless to say, the leptin effect also disappeared.
Whether one could now conclude that the ob/ob does not have a metabolic defect or that leptin or NPY deficiencies do not affect energy utilization is, however, far from clear. As pointed out in the response by Erikson et al., a normal resting metabolism in the ob/ob mouse is not consistent with other aspects of its phenotype, that is, abnormally low body temperature, reduced locomotor activity, and considerably greater feed efficiency (food intake divided by body weight, as suggested by Himms-Hagen). These inconsistencies could suggest that some normalization is still necessary in order to compare lean animals with the ob/ob mouse. The ob/ob mouse, after all, has a much larger surface area and more carcass water than a lean counterpart along with having more fat than "metabolically active" tissue. If vO 2 is expressed as a function of fat-free mass (water and carcass lean mass; FFM), then the ob/ob mouse retains its hypometabolic nature and leptin raises vO 2 to that found in lean mice (Table 1) . Studies showing reduced vO 2 in ob/ob mice have either used a comparison of weight-matched non-ob/ob mice with ob/ob mice or have normalized the data against mass or surface area (4, 5) . Unfortunately, any normalization of vO 2 (using ratios) is still somewhat controversial because the regression line for vO 2 versus fat-free mass or mass does not have a zero intercept, violating one of the assumptions necessary for using ratio data (6) 
